Comparison of Sensimed Triggerfish With Goldmann Applanation Tonometry and Perkins Tonometry
NCT ID: NCT01391078
Last Updated: 2012-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2011-06-30
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sensimed Triggerfish
Sensimed Triggerfish Sensor
IOP will be monitored for 24 hours
Goldmann Applanation Tonometry/Perkins Tonometry
Goldmann Applanation Tonometry, Perkins Tonometry
IOP will be measured every two hours within 24 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sensimed Triggerfish Sensor
IOP will be monitored for 24 hours
Goldmann Applanation Tonometry, Perkins Tonometry
IOP will be measured every two hours within 24 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must be ≥ 18 years old
* Diagnosis of primary open angle glaucoma (EGS criteria)
* Similar behaviour of IOP in both eyes in former IOP profiles
* Patient has consented to be in the trial and signed informed consent is available before any study related procedures are carried out
* Visual Acuity of 20/200 or better in both eyes
* Ability of subject to understand the character and individual consequences of the study
* For women with childbearing potential, adequate contraception
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sensimed AG
INDUSTRY
Katrin Lorenz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katrin Lorenz
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz
Mainz, RLP, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sensimed Triggerfish11/01
Identifier Type: -
Identifier Source: org_study_id